Article 5FYSN Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontli

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontli

by
from Morbidity and Mortality Weekly Report (MMWR) on (#5FYSN)
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (>=14 days after second dose) and 80% for partial immunization (>=14 days after first dose but before second dose) in real-world conditions.
External Content
Source RSS or Atom Feed
Feed Location http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Feed Title Morbidity and Mortality Weekly Report (MMWR)
Feed Link https://www.cdc.gov/mmwr/index.html
Reply 0 comments